Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol FTRE
- Company Fortrea Holdings Inc.
- Price $18.65
- Changes Percentage 0
- Change 0
- Day Low $18.53
- Day High $19.42
- Year High $41.02
- Year Low $16.53
- Market Cap $1,672,905,000
- Price Avg 50 EMA (D) $19.61
- Price Avg 200 EMA (D) $25.31
- Exchange NASDAQ
- Volume 754,403
- Average Volume 1,231,545
- Open $18.84
- Previous Close $18.65
- EPS -2.44
- PE -7.64
- Earnings Announcement 2025-03-10 04:00:00
- Shares Outstanding $89,700,000
Company brief: FORTREA HOLDINGS INC. (FTRE )
- Healthcare
- Biotechnology
- Mr. Thomas H. Pike
- https://www.fortrea.com
- US
- N/A
- 06-20-2023
- US34965K1079
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
FTRE Corporation News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
accesswire.com -- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE). Such investors are adv...